RecruitingNCT06608277
Comparing ketamine, nerve blocks, and combined approaches for PTSD and post-TBI headaches
About this title
Read the official source — NCT06608277Medication studyAges 18+United States
Understand this study
Who could participate?
Listed age limits: from 18 years.
- Listed locations
- Chicago and 2 more locationsSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: July 2, 2025
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 175
- Sponsor
- Northwestern University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- COMBINATION_PRODUCT, Medication / drug, OTHER, PROCEDURE
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT06608277
- Official title
Show the full official title
Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial Comparing Ketamine, Stellate Ganglion Blocks and Combination Treatment to Sham Therapies for Traumatic Brain Injury-Associated Headaches and Post-Traumatic Stress Disorder
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Chicago · Bethesda · Fort Bragg
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Northwestern University, a university.
Does this study involve medication?
Yes. The study involves medication, including Group B active comparator.
Who can participate?
Listed age limits: from 18 years.
Is this study still recruiting?
The registry lists this study as recruiting.
